Alimera Sciences, Inc. (ALIM) has an overall financial health rating of C- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-09-13.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2024-09-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-12 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-10 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-09-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-08-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-08-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-08-28 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
